A study confirmed that loss of ARID1A in EBV‐positive gastric cancer was partly regulated by EBV‐encoded miRNAs21; meanwhile, ARID1A loss increased the susceptibility of gastric epithelial cells to EBV infection and promoted gastric tumorigenesis.22 Here, ARID1A is linked to Epstein-Barr virus infection.